Correlation Engine 2.0
Clear Search sequence regions


  • activity (5)
  • agar (1)
  • azalomycin f5a (5)
  • F5a (2)
  • humans (1)
  • macrolides (2)
  • methicillin (8)
  • MRSA (3)
  • staphylococcus (1)
  • Sizes of these terms reflect their relevance to your search.

    To discover anti-methicillin-resistant Staphylococcus aureus (anti-MRSA) microbial natural products or their derivatives. Azalomycin F5a (1) was prepared through fermentation of Streptomyces hygroscopicus var. azalomyceticus, and its derivatives were synthesized through hydrocarbylation in hydrocarbyl alcoholic-AcOH (4 : 1) and subsequent demalonylation with 2 mol·L(-1) KOH in MeOH-H2O (7 : 3). Their activities against MRSA ATCC 33592 and three clinical MRSA isolates were evaluated by the agar diffusion and broth microdilution methods. Four demalonylazalomycin F5a derivatives 2 to 5 were synthesized. The anti-MRSA activity assay indicated that compounds 1 to 5 showed remarkable activity against MRSA, and their minimum inhibitory concentrations (MICs) were respectively 3.0-4.0, 0.5-1.0, 0.67-1.0, 0.67-0.83, and 0.5-0.83 μg·mL(-1). Azalomycin F5a and the demalonylazalomycin F5a derivatives 2-5 showed remarkable anti-MRSA activity, and the anti-MRSA activities of 2 to 5 were higher than that of 1, while the anti-MRSA activities of 2 to 5 showed no obvious differences. It was also shown that the malonyl monoester group of azalomycin F5a was less important for its anti-MRSA activity. Copyright © 2014 China Pharmaceutical University. Published by Elsevier B.V. All rights reserved.

    Citation

    Gan-Jun Yuan, Pei-Bo Li, Jun Yang, Hui-Zhong Pang, Ying Pei. Anti-methicillin-resistant Staphylococcus aureus assay of azalomycin F5a and its derivatives. Chinese journal of natural medicines. 2014 Apr;12(4):309-13

    Expand section icon Mesh Tags

    Expand section icon Substances


    PMID: 24863359

    View Full Text